CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 2.29: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.40%
Annual Rate
KRW 200.00Paid unknown
Payout Ratio
13.8%Sustainable
Last Ex-Dividend
Mar 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
451.19BKRW325.46M · vs all stocks (USD)
Trailing P/E
15.20xRevenue (TTM)
582.33BKRW420.05M · vs all stocks (USD)
Profit Margin
7.49%Beta
0.8890xvs all stocks
52-Week Change
-49.04%vs all stocks
Forward Annual Dividend Yield
1.40%vs all stocks
Market Capitalization
451.19BKRW325.46M · vs all stocks (USD)
Enterprise Value
524.49BKRW378.32M · vs all stocks (USD)
Trailing P/E
15.20xForward P/E
10.15xPEG Ratio
-0.0568xPrice to Sales (TTM)
0.7748xPrice to Book (MRQ)
1.81xEnterprise to Revenue
0.9010xEnterprise to EBITDA
11.02xGross Margin
38.33%Profit Margin
7.49%Operating Margin
2.45%Return on Assets (TTM)
2.79%Return on Equity (TTM)
18.50%Revenue (TTM)
582.33BKRW420.05M · vs all stocks (USD)
Revenue per Share (TTM)
18.69KKRWUpdated Sep 20, 2026Quarterly Revenue Growth
6.80%Gross Profit (TTM)
230.53BKRW166.29M · vs all stocks (USD)
EBITDA (TTM)
54.91BKRW39.61M · vs all stocks (USD)
Net Income (TTM)
43.61BKRW31.46M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.77%Operating Cash Flow (TTM)
35.44BKRW25.57M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
10.27BKRW7.41M · vs all stocks (USD)
Forward Annual Dividend Rate
200.00KRWUpdated Sep 20, 2026Forward Annual Dividend Yield
1.40%vs all stocks
Payout Ratio
13.78%Minority Interest (Equity)
-6.91BKRWFY2025 · Dec 31, 2025Revenue
566.93BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
347.18BKRWFY2025 · Dec 31, 2025Gross Profit
219.75BKRWFY2025 · Dec 31, 2025Operating Income
19.50BKRW14.07M · vs all stocks (USD)
Pre-tax Income
31.75BKRWFY2025 · Dec 31, 2025Income Tax Expense
8.06BKRWFY2025 · Dec 31, 2025Net Income
23.70BKRWFY2025 · Dec 31, 2025EBIT
43.93BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
44.51BKRWFY2025 · Dec 31, 2025Research & Development
35.60BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
81.16BKRWFY2025 · Dec 31, 2025Other Operating Expenses
1.70BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
942.07MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
12.17BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
23.70BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
3.97BKRWFY2025 · Dec 31, 2025Operating Cash Flow
13.00BKRWFY2025 · Dec 31, 2025Free Cash Flow
-488.95MKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
64.85BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
23.70BKRWFY2025 · Dec 31, 2025Stock-based Compensation
215.08MKRWFY2025 · Dec 31, 2025Other Non-cash Items
9.34BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.65BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-17.60BKRWFY2025 · Dec 31, 2025Capital Expenditures
-13.48BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-3.64BKRWFY2025 · Dec 31, 2025Net Acquisitions
-15.88BKRWFY2025 · Dec 31, 2025Purchase of Investments
-4.50BKRWFY2025 · Dec 31, 2025Sale of Investments
26.12BKRWFY2025 · Dec 31, 2025Other Investing Activity
230.84MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-7.51BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-45.36BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-30.21BKRWFY2025 · Dec 31, 2025Common Stock Repurchase
-865.80KKRWFY2025 · Dec 31, 2025Common Dividends Paid
-60.16MKRWFY2025 · Dec 31, 2025Other Financing Charges
9.55BKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-66.08BKRWFY2025 · Dec 31, 2025Shares Outstanding
31.51MSharesUpdated Sep 20, 2026Float Shares
20.60MSharesUpdated Sep 20, 2026% Held by Insiders
34.45%vs all stocks
% Held by Institutions
4.93%vs all stocks
Total Cash (MRQ)
60.37BKRW43.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.92KKRWUpdated Sep 20, 2026Total Debt (MRQ)
131.15BKRW94.60M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5036xCurrent Ratio (MRQ)
1.06xBook Value per Share (MRQ)
7.93KKRWUpdated Sep 20, 2026Total Assets
573.03BKRW413.34M · vs all stocks (USD)
Total Current Assets
221.97BKRWFY2025 · Dec 31, 2025Total Liabilities
333.52BKRWFY2025 · Dec 31, 2025Total Non-current Assets
351.07BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
102.55BKRWFY2025 · Dec 31, 2025Total Current Liabilities
230.97BKRWFY2025 · Dec 31, 2025Cash
34.24MKRWFY2025 · Dec 31, 2025Cash Equivalents
64.81BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
64.85BKRWFY2025 · Dec 31, 2025Other Short-term Investments
110.00MKRWFY2025 · Dec 31, 2025Accounts Receivable
46.85BKRWFY2025 · Dec 31, 2025Inventory
100.52BKRWFY2025 · Dec 31, 2025Accounts Payable
47.76BKRWFY2025 · Dec 31, 2025Short-term Debt
120.83BKRWFY2025 · Dec 31, 2025Other Current Liabilities
1.05KKRWFY2025 · Dec 31, 2025Long-term Debt
23.58BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-460.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
31.64BKRWFY2025 · Dec 31, 2025Retained Earnings
105.72BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
239.51BKRW172.77M · vs all stocks (USD)
Treasury Stock
2.31BKRWFY2025 · Dec 31, 202552-Week Low
11.25KKRWUpdated Sep 20, 202652-Week High
45.05KKRWUpdated Sep 20, 202652-Week Change
-49.04%vs all stocks
Beta
0.8890xvs all stocks
50-Day MA
14.58KKRWUpdated Sep 20, 2026200-Day MA
25.99KKRWUpdated Sep 20, 2026Avg 10-Day Volume
310.88KSharesUpdated Sep 20, 2026Avg 30-Day Volume
449.71KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
937.00KRWUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.29: grey zoneSignificant
Altman Z-Score: 2.29
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Newron Pharmaceuticals SpA
Tier 1ProductionApproval-Gated PipelineRuleRisk
BioAge Labs, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hubei Guangji Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cuorips Inc.
Tier 1ProductionApproval-Gated PipelineRule
Golden Throat Holdings Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Dishman Carbogen Amcis Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Larimar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Xinguang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanxi C&Y Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Mingxin New Material Co. Ltd.
1 interpretationDecline With Range Expansion And Drawdown
Changzhou Kaidi Electrical Co., Ltd.
1 interpretationDecline With Range Expansion And Drawdown
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
1 interpretationDecline With Range Expansion And Drawdown